Oral gatifloxacin in outpatient community-acquired pneumonia: results from TeqCES, a community-based, open-label, multicenter study
- 1 September 2002
- journal article
- clinical trial
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 44 (1) , 85-91
- https://doi.org/10.1016/s0732-8893(02)00447-9
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Macrolide Resistance Among Invasive Streptococcus pneumoniae IsolatesPublished by American Medical Association (AMA) ,2001
- New Antibiotics in Pulmonary and Critical Care Medicine: Focus on Advanced Generation Quinolones and CephalosporinsSeminars in Respiratory and Critical Care Medicine, 2000
- Susceptibility of bacterial isolates to gatifloxacin and ciprofloxacin from clinical trials 1997–1998International Journal of Antimicrobial Agents, 2000
- Clinical Pharmacology of Gatifloxacin, a New FluoroquinoloneClinical Infectious Diseases, 2000
- Practice Guidelines for the Management of Community-Acquired Pneumonia in AdultsClinical Infectious Diseases, 2000
- In vitro antibacterial spectrum of a new broad-spectrum 8-methoxy fluoroquinolone, gatifloxacinJournal of Antimicrobial Chemotherapy, 2000
- A review of the comparative in-vitro activities of 12 antimicrobial agents, with a focus on five new ‘respiratory quinolones’Journal of Antimicrobial Chemotherapy, 1999
- Incidence, etiologic pathogens, and diagnostic testing of community-acquired pneumoniaCurrent Opinion in Pulmonary Medicine, 1997
- A Prediction Rule to Identify Low-Risk Patients with Community-Acquired PneumoniaNew England Journal of Medicine, 1997
- Community-Acquired PneumoniaNew England Journal of Medicine, 1995